Smoking in individuals with cirrhosis worsens inflammation, fibrogenesis, and angiogenesis, and increases the risk of extrahepatic cancers in advanced chronic liver disease (ACLD).
A study published in the Liver International journal found that smoking increases inflammation, fibrogenesis, and angiogenesis, as well as the risk for extrahepatic malignancies in ACLD.
According to the study, 40% of patients with ACLD have a history of smoking, yet little is known about the effects of smoking on ACLD outcomes.
No direct quote available in the given text.
Author's summary: Smoking worsens ACLD outcomes by increasing inflammation and cancer risk.